A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy

被引:1
作者
Fukushima, Daizo [1 ]
Imai, Shigeki [2 ]
Nishino, Noriyuki [1 ]
Hamada, Kohichi [3 ]
Horikawa, Yoshinori [1 ]
Shiwa, Yoshiki [1 ]
Nishida, Shinya [1 ]
Koyanagi, Ryota [3 ]
Wada, Hitoshi [4 ]
Sakuma, Hideo [5 ]
机构
[1] Southern Tohoku Gen Hosp, Dept Gastroenterol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[2] Southern Tohoku Res Inst Neurosci, Dept Radiol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[3] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima 9601295, Japan
[4] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan
[5] Southern Tohoku Res Inst Neurosci, Dept Pathol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Arterio-portal shunt; Transarterial chemoembolization; Radiation therapy; DRUG-ELUTING BEADS; ARTERIOPORTAL SHUNT; EFFICACY; SAFETY;
D O I
10.1007/s12328-020-01124-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Portal vein tumor thrombosis (PVTT) is an extremely locally advanced form of hepatocellular carcinoma. The natural median survival time of patients with hepatocellular carcinoma with PVTT is 2.7 to 4.0 months. A 63-year-old woman visited our clinic complaining of abdominal distention and appetite loss, which she had had for 3 weeks prior to admission. A contrast-enhanced computed tomography scan showed double hepatocellular carcinomas with Type III PVTT and massive ascites caused by arterio-portal shunts within the PVTT. The ascites could not be treated by concentrated ascites reinfusion therapy or diuretics. Transarterial embolization using microspheres followed by radiation therapy against PVTT and five courses of transarterial chemoembolization using microspheres and cisplatin led to the maintaining of complete remission of both ascites and tumors for over 12 months after treatment. Fluoroglucose accumulation of PVTT showed 11.2 as a maximum standard uptake value on positron emission tomography before treatment. No fluoroglucose accumulation within PVTT was observed for over 12 months following treatment. Transarterial chemoembolization using microspheres followed by radiation therapy against Type III PVTT may result in drastic anti-cancer effects and improvement of both serum albumin and intractable ascites after treatment of arterio-portal shunts within the PVTT causing portal hypertension.
引用
收藏
页码:847 / 854
页数:8
相关论文
共 50 条
  • [21] Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis
    Kang, Jingbo
    Nie, Qing
    Du, Rui
    Zhang, Liping
    Zhang, Jun
    Li, Qiliang
    Li, Jianguo
    Qi, Wenjie
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 43 - 50
  • [22] Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
    Luo, Jun
    Guo, Rong-Ping
    Lai, Eric C. H.
    Zhang, Yao-Jun
    Lau, Wan Yee
    Chen, Min-Shan
    Shi, Ming
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (02) : 413 - 420
  • [23] Is hepatic resection better than transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis?
    Ibrahim, Canine
    Parra, Natalia
    Macedo, Francisco Igor
    Yakoub, Danny
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (06) : 1064 - 1072
  • [24] Radiation Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
    Park, Seung Gyu
    Kim, Jin Hee
    Byun, Sang Jun
    Kim, Ok Bae
    Hwang, Jae Seok
    Oh, Young Kee
    Choi, Tae Jin
    RADIATION ONCOLOGY JOURNAL, 2011, 29 (01): : 36 - 43
  • [25] Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis
    Sui, Wei-Fan
    Li, Jian-Yun
    Fu, Jian-Hua
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (03):
  • [26] Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
    Zheng, Ninggang
    Wei, Xiaodong
    Zhang, Dongzhi
    Chai, Wenxiao
    Che, Ming
    Wang, Jiangye
    Du, Binbin
    MEDICINE, 2016, 95 (26)
  • [27] Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis
    Leng, Jian-Jun
    Xu, Yin-Zhe
    Dong, Jia-Hong
    ANZ JOURNAL OF SURGERY, 2016, 86 (10) : 816 - 820
  • [28] Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis
    Abdella H.
    Shaker M.K.
    Montasser I.F.
    Sobhi M.
    Aly H.
    Sayed A.
    Saleh S.
    El Dorry A.
    Indian Journal of Gastroenterology, 2018, 37 (2) : 127 - 132
  • [29] Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Yang, Biao
    You, Xin
    Yuan, Min Lan
    Qin, Tian Qiang
    Duan, Lin Jia
    He, Jiao
    Fei, Ze Jun
    Zhou, Xuan
    Zan, Rui Yu
    Liao, Zheng Yin
    HEPATITIS MONTHLY, 2016, 16 (08)
  • [30] Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
    You, Ran
    Cheng, Yuan
    Diao, Lingfeng
    Wang, Chendong
    Leng, Bin
    Yu, Zeyu
    Xu, Qingyu
    Yin, Guowen
    BIOMEDICINES, 2024, 12 (09)